Preliminary UK GDP data for Q1 is expected to show a rebound, though March figures could reveal contraction amid Iran war fallout. The UK’s preliminary Q1 GDP report, due Thursday, is forecast to show a 0.6% expansion, rebounding from a weak 0.1% gain in Q4 2025. The impro
FWDI’s SOL position, acquired at $232.08 per token, now trades far below cost, driving near-$1B paper losses. Forward Industries (NASDAQ: FWDI) holds 6,979,967.46 SOL, purchased at an average of $232.08 per token, now marking a near-$1 billion unrealized loss. The firm’s S
PBOC sets the daily reference rate at 6.8401 CNY per USD, the strongest level in three years, lifting offshore yuan. The offshore yuan strengthened to its highest level since February 2023, trading at 6.8401 CNY per USD. The move follows the People’s Bank of China setting
StubHub expects $9.9B-$10.1B GMS in 2026 StubHub has reiterated its 2026 outlook, expecting gross merchandise sales of $9.9B-$10.1B. The company reported a solid start to 2026, with top line growth and increased profitability. In Q1 2026, GMS increased 7% to $2.2
Motorsport Games reports Q1 2026 revenue of $4 million, up over 100% year-on-year, and outlines future growth plans. Motorsport Games (MSGM) announced Q1 2026 revenue of $4 million, more than doubling its year-on-year performance. The company attributed the growth to impro
The tanker’s transit marks the third Chinese supertanker passage through the strait amid heightened regional tensions and oil trade shifts. A Chinese very large crude carrier (VLCC) carrying nearly 2 million barrels of Iraqi Basrah Medium crude exited the Strait of Hormuz
Aytu BioPharma projects $6M-$7M in quarterly sales and marketing spending amid rising EXXUA prescription volumes. Aytu BioPharma outlined a $6M-$7M quarterly sales and marketing expenditure range for fiscal Q3 2026. The company reported over 920 EXXUA prescriptions in Apri
Inovio Pharmaceuticals confirms financial runway through Q1 2027 as its lead drug candidate nears October 2026 regulatory decision. Inovio Pharmaceuticals announced its cash runway will extend into Q1 2027, providing financial stability as it advances INO-3107 toward a reg
Traders remain cautious as the currency pair stabilizes after six consecutive sessions of gains before key trade discussions. The USD/CAD pair traded steady around 1.3700 in Asian hours Thursday, pausing after six straight days of gains. Market participants adopted a wait-
PBOC sets daily USD/CNY reference rate below Reuters poll estimate, signaling modest depreciation pressure on the yuan. The People’s Bank of China set the USD/CNY reference rate at 6.8401 for Thursday’s session, down from 6.8426 the previous day but weaker than the 6.7888